⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21845382 | 1.00 | — | — | |
| SCHEMBL22968982 | 0.72 | — | — | |
| SCHEMBL6091832 | 0.72 | — | — | |
| SCHEMBL22969094 | 0.72 | — | — | |
| SCHEMBL22049076 | 0.69 | — | — | |
| SCHEMBL21287467 | 0.69 | — | — | |
| SCHEMBL21287466 | 0.69 | — | — | |
| SCHEMBL21287465 | 0.69 | — | — | |
| SCHEMBL2693034 | 0.67 | — | — | |
| SCHEMBL14491061 | 0.66 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020061103-A1 | FUSED TRICYCLIC RING DERIVATIVES AS SRC HOMOLOGY-2 PHOSPHATASE INHIBITORS | NIKANG THERAPEUTICS, INC. (US) | 2020-03-26 | — | — | WO | disclosed |